Global Celecoxib API Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 106

Published Date: 22 Mar 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Celecoxib API market size was valued at USD 58 million in 2022 and is forecast to a readjusted size of USD 79 million by 2029 with a CAGR of 4.7% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global key players of celecoxib API include Pfizer, Jiangxi Synergy, ScinoPharm, Jiangsu Hengrui Medicine, Jiangsu Chiatai Qingjiang, etc. The top five players hold a share over 73%. Asia Pacific is the largest market, has a share about 43%, followed by North America and Europe, with share 28% and 25%, separately.

Celecoxib API refers to the active pharmaceutical ingredient (API) of the drug Celecoxib, which is a non-steroidal anti-inflammatory drug (NSAID) used to relieve pain, inflammation, and stiffness caused by conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. The Celecoxib API is the chemical compound responsible for the therapeutic effects of the drug. It is a selective cyclooxygenase-2 (COX-2) inhibitor, which means it works by blocking the production of prostaglandins, which are chemicals produced by the body in response to injury or inflammation. By reducing the production of prostaglandins, Celecoxib can help relieve pain, reduce inflammation, and improve joint mobility. The Celecoxib API is typically manufactured by pharmaceutical companies in accordance with strict quality control standards to ensure its purity, potency, and safety. It is then used to produce finished dosage forms of Celecoxib, such as tablets or capsules, which are prescribed by healthcare professionals to treat various inflammatory conditions.

This report is a detailed and comprehensive analysis for global Celecoxib API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Celecoxib API market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2018-2029
Global Celecoxib API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2018-2029
Global Celecoxib API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Kg), 2018-2029
Global Celecoxib API market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (US$/Kg), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Celecoxib API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Celecoxib API market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Teva Pharmaceuticals, Viatris(Mylan), ScinoPharm and Jiangxi Synergy, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Celecoxib API market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Standard grade Celecoxib API
    Micronized Celecoxib API

Market segment by Application
    Pharmaceutical
    Laboratory

Major players covered
    Pfizer
    Teva Pharmaceuticals
    Viatris(Mylan)
    ScinoPharm
    Jiangxi Synergy
    Jiangsu Hengrui Medicine
    Jiangsu Chiatai Qingjiang
    Hisun Pharmaceutical Nantong
    Aurobindo Pharma
    Punjab Chemicals

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Celecoxib API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Celecoxib API, with price, sales, revenue and global market share of Celecoxib API from 2018 to 2023.
Chapter 3, the Celecoxib API competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Celecoxib API breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Celecoxib API market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Celecoxib API.
Chapter 14 and 15, to describe Celecoxib API sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Celecoxib API
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Celecoxib API Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Standard grade Celecoxib API
        1.3.3 Micronized Celecoxib API
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Celecoxib API Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Pharmaceutical
        1.4.3 Laboratory
    1.5 Global Celecoxib API Market Size & Forecast
        1.5.1 Global Celecoxib API Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Celecoxib API Sales Quantity (2018-2029)
        1.5.3 Global Celecoxib API Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 Pfizer
        2.1.1 Pfizer Details
        2.1.2 Pfizer Major Business
        2.1.3 Pfizer Celecoxib API Product and Services
        2.1.4 Pfizer Celecoxib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Pfizer Recent Developments/Updates
    2.2 Teva Pharmaceuticals
        2.2.1 Teva Pharmaceuticals Details
        2.2.2 Teva Pharmaceuticals Major Business
        2.2.3 Teva Pharmaceuticals Celecoxib API Product and Services
        2.2.4 Teva Pharmaceuticals Celecoxib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Teva Pharmaceuticals Recent Developments/Updates
    2.3 Viatris(Mylan)
        2.3.1 Viatris(Mylan) Details
        2.3.2 Viatris(Mylan) Major Business
        2.3.3 Viatris(Mylan) Celecoxib API Product and Services
        2.3.4 Viatris(Mylan) Celecoxib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Viatris(Mylan) Recent Developments/Updates
    2.4 ScinoPharm
        2.4.1 ScinoPharm Details
        2.4.2 ScinoPharm Major Business
        2.4.3 ScinoPharm Celecoxib API Product and Services
        2.4.4 ScinoPharm Celecoxib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 ScinoPharm Recent Developments/Updates
    2.5 Jiangxi Synergy
        2.5.1 Jiangxi Synergy Details
        2.5.2 Jiangxi Synergy Major Business
        2.5.3 Jiangxi Synergy Celecoxib API Product and Services
        2.5.4 Jiangxi Synergy Celecoxib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Jiangxi Synergy Recent Developments/Updates
    2.6 Jiangsu Hengrui Medicine
        2.6.1 Jiangsu Hengrui Medicine Details
        2.6.2 Jiangsu Hengrui Medicine Major Business
        2.6.3 Jiangsu Hengrui Medicine Celecoxib API Product and Services
        2.6.4 Jiangsu Hengrui Medicine Celecoxib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Jiangsu Hengrui Medicine Recent Developments/Updates
    2.7 Jiangsu Chiatai Qingjiang
        2.7.1 Jiangsu Chiatai Qingjiang Details
        2.7.2 Jiangsu Chiatai Qingjiang Major Business
        2.7.3 Jiangsu Chiatai Qingjiang Celecoxib API Product and Services
        2.7.4 Jiangsu Chiatai Qingjiang Celecoxib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Jiangsu Chiatai Qingjiang Recent Developments/Updates
    2.8 Hisun Pharmaceutical Nantong
        2.8.1 Hisun Pharmaceutical Nantong Details
        2.8.2 Hisun Pharmaceutical Nantong Major Business
        2.8.3 Hisun Pharmaceutical Nantong Celecoxib API Product and Services
        2.8.4 Hisun Pharmaceutical Nantong Celecoxib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Hisun Pharmaceutical Nantong Recent Developments/Updates
    2.9 Aurobindo Pharma
        2.9.1 Aurobindo Pharma Details
        2.9.2 Aurobindo Pharma Major Business
        2.9.3 Aurobindo Pharma Celecoxib API Product and Services
        2.9.4 Aurobindo Pharma Celecoxib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Aurobindo Pharma Recent Developments/Updates
    2.10 Punjab Chemicals
        2.10.1 Punjab Chemicals Details
        2.10.2 Punjab Chemicals Major Business
        2.10.3 Punjab Chemicals Celecoxib API Product and Services
        2.10.4 Punjab Chemicals Celecoxib API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Punjab Chemicals Recent Developments/Updates

3 Competitive Environment: Celecoxib API by Manufacturer
    3.1 Global Celecoxib API Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Celecoxib API Revenue by Manufacturer (2018-2023)
    3.3 Global Celecoxib API Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Celecoxib API by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Celecoxib API Manufacturer Market Share in 2022
        3.4.2 Top 6 Celecoxib API Manufacturer Market Share in 2022
    3.5 Celecoxib API Market: Overall Company Footprint Analysis
        3.5.1 Celecoxib API Market: Region Footprint
        3.5.2 Celecoxib API Market: Company Product Type Footprint
        3.5.3 Celecoxib API Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Celecoxib API Market Size by Region
        4.1.1 Global Celecoxib API Sales Quantity by Region (2018-2029)
        4.1.2 Global Celecoxib API Consumption Value by Region (2018-2029)
        4.1.3 Global Celecoxib API Average Price by Region (2018-2029)
    4.2 North America Celecoxib API Consumption Value (2018-2029)
    4.3 Europe Celecoxib API Consumption Value (2018-2029)
    4.4 Asia-Pacific Celecoxib API Consumption Value (2018-2029)
    4.5 South America Celecoxib API Consumption Value (2018-2029)
    4.6 Middle East and Africa Celecoxib API Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Celecoxib API Sales Quantity by Type (2018-2029)
    5.2 Global Celecoxib API Consumption Value by Type (2018-2029)
    5.3 Global Celecoxib API Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Celecoxib API Sales Quantity by Application (2018-2029)
    6.2 Global Celecoxib API Consumption Value by Application (2018-2029)
    6.3 Global Celecoxib API Average Price by Application (2018-2029)

7 North America
    7.1 North America Celecoxib API Sales Quantity by Type (2018-2029)
    7.2 North America Celecoxib API Sales Quantity by Application (2018-2029)
    7.3 North America Celecoxib API Market Size by Country
        7.3.1 North America Celecoxib API Sales Quantity by Country (2018-2029)
        7.3.2 North America Celecoxib API Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Celecoxib API Sales Quantity by Type (2018-2029)
    8.2 Europe Celecoxib API Sales Quantity by Application (2018-2029)
    8.3 Europe Celecoxib API Market Size by Country
        8.3.1 Europe Celecoxib API Sales Quantity by Country (2018-2029)
        8.3.2 Europe Celecoxib API Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Celecoxib API Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Celecoxib API Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Celecoxib API Market Size by Region
        9.3.1 Asia-Pacific Celecoxib API Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Celecoxib API Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Celecoxib API Sales Quantity by Type (2018-2029)
    10.2 South America Celecoxib API Sales Quantity by Application (2018-2029)
    10.3 South America Celecoxib API Market Size by Country
        10.3.1 South America Celecoxib API Sales Quantity by Country (2018-2029)
        10.3.2 South America Celecoxib API Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Celecoxib API Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Celecoxib API Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Celecoxib API Market Size by Country
        11.3.1 Middle East & Africa Celecoxib API Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Celecoxib API Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Celecoxib API Market Drivers
    12.2 Celecoxib API Market Restraints
    12.3 Celecoxib API Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Celecoxib API and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Celecoxib API
    13.3 Celecoxib API Production Process
    13.4 Celecoxib API Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Celecoxib API Typical Distributors
    14.3 Celecoxib API Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Celecoxib API Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Celecoxib API Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 4. Pfizer Major Business
    Table 5. Pfizer Celecoxib API Product and Services
    Table 6. Pfizer Celecoxib API Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. Pfizer Recent Developments/Updates
    Table 8. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 9. Teva Pharmaceuticals Major Business
    Table 10. Teva Pharmaceuticals Celecoxib API Product and Services
    Table 11. Teva Pharmaceuticals Celecoxib API Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Teva Pharmaceuticals Recent Developments/Updates
    Table 13. Viatris(Mylan) Basic Information, Manufacturing Base and Competitors
    Table 14. Viatris(Mylan) Major Business
    Table 15. Viatris(Mylan) Celecoxib API Product and Services
    Table 16. Viatris(Mylan) Celecoxib API Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Viatris(Mylan) Recent Developments/Updates
    Table 18. ScinoPharm Basic Information, Manufacturing Base and Competitors
    Table 19. ScinoPharm Major Business
    Table 20. ScinoPharm Celecoxib API Product and Services
    Table 21. ScinoPharm Celecoxib API Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. ScinoPharm Recent Developments/Updates
    Table 23. Jiangxi Synergy Basic Information, Manufacturing Base and Competitors
    Table 24. Jiangxi Synergy Major Business
    Table 25. Jiangxi Synergy Celecoxib API Product and Services
    Table 26. Jiangxi Synergy Celecoxib API Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Jiangxi Synergy Recent Developments/Updates
    Table 28. Jiangsu Hengrui Medicine Basic Information, Manufacturing Base and Competitors
    Table 29. Jiangsu Hengrui Medicine Major Business
    Table 30. Jiangsu Hengrui Medicine Celecoxib API Product and Services
    Table 31. Jiangsu Hengrui Medicine Celecoxib API Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Jiangsu Hengrui Medicine Recent Developments/Updates
    Table 33. Jiangsu Chiatai Qingjiang Basic Information, Manufacturing Base and Competitors
    Table 34. Jiangsu Chiatai Qingjiang Major Business
    Table 35. Jiangsu Chiatai Qingjiang Celecoxib API Product and Services
    Table 36. Jiangsu Chiatai Qingjiang Celecoxib API Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Jiangsu Chiatai Qingjiang Recent Developments/Updates
    Table 38. Hisun Pharmaceutical Nantong Basic Information, Manufacturing Base and Competitors
    Table 39. Hisun Pharmaceutical Nantong Major Business
    Table 40. Hisun Pharmaceutical Nantong Celecoxib API Product and Services
    Table 41. Hisun Pharmaceutical Nantong Celecoxib API Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. Hisun Pharmaceutical Nantong Recent Developments/Updates
    Table 43. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
    Table 44. Aurobindo Pharma Major Business
    Table 45. Aurobindo Pharma Celecoxib API Product and Services
    Table 46. Aurobindo Pharma Celecoxib API Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 47. Aurobindo Pharma Recent Developments/Updates
    Table 48. Punjab Chemicals Basic Information, Manufacturing Base and Competitors
    Table 49. Punjab Chemicals Major Business
    Table 50. Punjab Chemicals Celecoxib API Product and Services
    Table 51. Punjab Chemicals Celecoxib API Sales Quantity (Kg), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 52. Punjab Chemicals Recent Developments/Updates
    Table 53. Global Celecoxib API Sales Quantity by Manufacturer (2018-2023) & (Kg)
    Table 54. Global Celecoxib API Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 55. Global Celecoxib API Average Price by Manufacturer (2018-2023) & (US$/Kg)
    Table 56. Market Position of Manufacturers in Celecoxib API, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 57. Head Office and Celecoxib API Production Site of Key Manufacturer
    Table 58. Celecoxib API Market: Company Product Type Footprint
    Table 59. Celecoxib API Market: Company Product Application Footprint
    Table 60. Celecoxib API New Market Entrants and Barriers to Market Entry
    Table 61. Celecoxib API Mergers, Acquisition, Agreements, and Collaborations
    Table 62. Global Celecoxib API Sales Quantity by Region (2018-2023) & (Kg)
    Table 63. Global Celecoxib API Sales Quantity by Region (2024-2029) & (Kg)
    Table 64. Global Celecoxib API Consumption Value by Region (2018-2023) & (USD Million)
    Table 65. Global Celecoxib API Consumption Value by Region (2024-2029) & (USD Million)
    Table 66. Global Celecoxib API Average Price by Region (2018-2023) & (US$/Kg)
    Table 67. Global Celecoxib API Average Price by Region (2024-2029) & (US$/Kg)
    Table 68. Global Celecoxib API Sales Quantity by Type (2018-2023) & (Kg)
    Table 69. Global Celecoxib API Sales Quantity by Type (2024-2029) & (Kg)
    Table 70. Global Celecoxib API Consumption Value by Type (2018-2023) & (USD Million)
    Table 71. Global Celecoxib API Consumption Value by Type (2024-2029) & (USD Million)
    Table 72. Global Celecoxib API Average Price by Type (2018-2023) & (US$/Kg)
    Table 73. Global Celecoxib API Average Price by Type (2024-2029) & (US$/Kg)
    Table 74. Global Celecoxib API Sales Quantity by Application (2018-2023) & (Kg)
    Table 75. Global Celecoxib API Sales Quantity by Application (2024-2029) & (Kg)
    Table 76. Global Celecoxib API Consumption Value by Application (2018-2023) & (USD Million)
    Table 77. Global Celecoxib API Consumption Value by Application (2024-2029) & (USD Million)
    Table 78. Global Celecoxib API Average Price by Application (2018-2023) & (US$/Kg)
    Table 79. Global Celecoxib API Average Price by Application (2024-2029) & (US$/Kg)
    Table 80. North America Celecoxib API Sales Quantity by Type (2018-2023) & (Kg)
    Table 81. North America Celecoxib API Sales Quantity by Type (2024-2029) & (Kg)
    Table 82. North America Celecoxib API Sales Quantity by Application (2018-2023) & (Kg)
    Table 83. North America Celecoxib API Sales Quantity by Application (2024-2029) & (Kg)
    Table 84. North America Celecoxib API Sales Quantity by Country (2018-2023) & (Kg)
    Table 85. North America Celecoxib API Sales Quantity by Country (2024-2029) & (Kg)
    Table 86. North America Celecoxib API Consumption Value by Country (2018-2023) & (USD Million)
    Table 87. North America Celecoxib API Consumption Value by Country (2024-2029) & (USD Million)
    Table 88. Europe Celecoxib API Sales Quantity by Type (2018-2023) & (Kg)
    Table 89. Europe Celecoxib API Sales Quantity by Type (2024-2029) & (Kg)
    Table 90. Europe Celecoxib API Sales Quantity by Application (2018-2023) & (Kg)
    Table 91. Europe Celecoxib API Sales Quantity by Application (2024-2029) & (Kg)
    Table 92. Europe Celecoxib API Sales Quantity by Country (2018-2023) & (Kg)
    Table 93. Europe Celecoxib API Sales Quantity by Country (2024-2029) & (Kg)
    Table 94. Europe Celecoxib API Consumption Value by Country (2018-2023) & (USD Million)
    Table 95. Europe Celecoxib API Consumption Value by Country (2024-2029) & (USD Million)
    Table 96. Asia-Pacific Celecoxib API Sales Quantity by Type (2018-2023) & (Kg)
    Table 97. Asia-Pacific Celecoxib API Sales Quantity by Type (2024-2029) & (Kg)
    Table 98. Asia-Pacific Celecoxib API Sales Quantity by Application (2018-2023) & (Kg)
    Table 99. Asia-Pacific Celecoxib API Sales Quantity by Application (2024-2029) & (Kg)
    Table 100. Asia-Pacific Celecoxib API Sales Quantity by Region (2018-2023) & (Kg)
    Table 101. Asia-Pacific Celecoxib API Sales Quantity by Region (2024-2029) & (Kg)
    Table 102. Asia-Pacific Celecoxib API Consumption Value by Region (2018-2023) & (USD Million)
    Table 103. Asia-Pacific Celecoxib API Consumption Value by Region (2024-2029) & (USD Million)
    Table 104. South America Celecoxib API Sales Quantity by Type (2018-2023) & (Kg)
    Table 105. South America Celecoxib API Sales Quantity by Type (2024-2029) & (Kg)
    Table 106. South America Celecoxib API Sales Quantity by Application (2018-2023) & (Kg)
    Table 107. South America Celecoxib API Sales Quantity by Application (2024-2029) & (Kg)
    Table 108. South America Celecoxib API Sales Quantity by Country (2018-2023) & (Kg)
    Table 109. South America Celecoxib API Sales Quantity by Country (2024-2029) & (Kg)
    Table 110. South America Celecoxib API Consumption Value by Country (2018-2023) & (USD Million)
    Table 111. South America Celecoxib API Consumption Value by Country (2024-2029) & (USD Million)
    Table 112. Middle East & Africa Celecoxib API Sales Quantity by Type (2018-2023) & (Kg)
    Table 113. Middle East & Africa Celecoxib API Sales Quantity by Type (2024-2029) & (Kg)
    Table 114. Middle East & Africa Celecoxib API Sales Quantity by Application (2018-2023) & (Kg)
    Table 115. Middle East & Africa Celecoxib API Sales Quantity by Application (2024-2029) & (Kg)
    Table 116. Middle East & Africa Celecoxib API Sales Quantity by Region (2018-2023) & (Kg)
    Table 117. Middle East & Africa Celecoxib API Sales Quantity by Region (2024-2029) & (Kg)
    Table 118. Middle East & Africa Celecoxib API Consumption Value by Region (2018-2023) & (USD Million)
    Table 119. Middle East & Africa Celecoxib API Consumption Value by Region (2024-2029) & (USD Million)
    Table 120. Celecoxib API Raw Material
    Table 121. Key Manufacturers of Celecoxib API Raw Materials
    Table 122. Celecoxib API Typical Distributors
    Table 123. Celecoxib API Typical Customers
List of Figures
    Figure 1. Celecoxib API Picture
    Figure 2. Global Celecoxib API Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Celecoxib API Consumption Value Market Share by Type in 2022
    Figure 4. Standard grade Celecoxib API Examples
    Figure 5. Micronized Celecoxib API Examples
    Figure 6. Global Celecoxib API Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 7. Global Celecoxib API Consumption Value Market Share by Application in 2022
    Figure 8. Pharmaceutical Examples
    Figure 9. Laboratory Examples
    Figure 10. Global Celecoxib API Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 11. Global Celecoxib API Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 12. Global Celecoxib API Sales Quantity (2018-2029) & (Kg)
    Figure 13. Global Celecoxib API Average Price (2018-2029) & (US$/Kg)
    Figure 14. Global Celecoxib API Sales Quantity Market Share by Manufacturer in 2022
    Figure 15. Global Celecoxib API Consumption Value Market Share by Manufacturer in 2022
    Figure 16. Producer Shipments of Celecoxib API by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 17. Top 3 Celecoxib API Manufacturer (Consumption Value) Market Share in 2022
    Figure 18. Top 6 Celecoxib API Manufacturer (Consumption Value) Market Share in 2022
    Figure 19. Global Celecoxib API Sales Quantity Market Share by Region (2018-2029)
    Figure 20. Global Celecoxib API Consumption Value Market Share by Region (2018-2029)
    Figure 21. North America Celecoxib API Consumption Value (2018-2029) & (USD Million)
    Figure 22. Europe Celecoxib API Consumption Value (2018-2029) & (USD Million)
    Figure 23. Asia-Pacific Celecoxib API Consumption Value (2018-2029) & (USD Million)
    Figure 24. South America Celecoxib API Consumption Value (2018-2029) & (USD Million)
    Figure 25. Middle East & Africa Celecoxib API Consumption Value (2018-2029) & (USD Million)
    Figure 26. Global Celecoxib API Sales Quantity Market Share by Type (2018-2029)
    Figure 27. Global Celecoxib API Consumption Value Market Share by Type (2018-2029)
    Figure 28. Global Celecoxib API Average Price by Type (2018-2029) & (US$/Kg)
    Figure 29. Global Celecoxib API Sales Quantity Market Share by Application (2018-2029)
    Figure 30. Global Celecoxib API Consumption Value Market Share by Application (2018-2029)
    Figure 31. Global Celecoxib API Average Price by Application (2018-2029) & (US$/Kg)
    Figure 32. North America Celecoxib API Sales Quantity Market Share by Type (2018-2029)
    Figure 33. North America Celecoxib API Sales Quantity Market Share by Application (2018-2029)
    Figure 34. North America Celecoxib API Sales Quantity Market Share by Country (2018-2029)
    Figure 35. North America Celecoxib API Consumption Value Market Share by Country (2018-2029)
    Figure 36. United States Celecoxib API Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 37. Canada Celecoxib API Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 38. Mexico Celecoxib API Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 39. Europe Celecoxib API Sales Quantity Market Share by Type (2018-2029)
    Figure 40. Europe Celecoxib API Sales Quantity Market Share by Application (2018-2029)
    Figure 41. Europe Celecoxib API Sales Quantity Market Share by Country (2018-2029)
    Figure 42. Europe Celecoxib API Consumption Value Market Share by Country (2018-2029)
    Figure 43. Germany Celecoxib API Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 44. France Celecoxib API Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 45. United Kingdom Celecoxib API Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 46. Russia Celecoxib API Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. Italy Celecoxib API Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. Asia-Pacific Celecoxib API Sales Quantity Market Share by Type (2018-2029)
    Figure 49. Asia-Pacific Celecoxib API Sales Quantity Market Share by Application (2018-2029)
    Figure 50. Asia-Pacific Celecoxib API Sales Quantity Market Share by Region (2018-2029)
    Figure 51. Asia-Pacific Celecoxib API Consumption Value Market Share by Region (2018-2029)
    Figure 52. China Celecoxib API Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 53. Japan Celecoxib API Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 54. Korea Celecoxib API Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 55. India Celecoxib API Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. Southeast Asia Celecoxib API Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Australia Celecoxib API Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. South America Celecoxib API Sales Quantity Market Share by Type (2018-2029)
    Figure 59. South America Celecoxib API Sales Quantity Market Share by Application (2018-2029)
    Figure 60. South America Celecoxib API Sales Quantity Market Share by Country (2018-2029)
    Figure 61. South America Celecoxib API Consumption Value Market Share by Country (2018-2029)
    Figure 62. Brazil Celecoxib API Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 63. Argentina Celecoxib API Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 64. Middle East & Africa Celecoxib API Sales Quantity Market Share by Type (2018-2029)
    Figure 65. Middle East & Africa Celecoxib API Sales Quantity Market Share by Application (2018-2029)
    Figure 66. Middle East & Africa Celecoxib API Sales Quantity Market Share by Region (2018-2029)
    Figure 67. Middle East & Africa Celecoxib API Consumption Value Market Share by Region (2018-2029)
    Figure 68. Turkey Celecoxib API Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 69. Egypt Celecoxib API Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 70. Saudi Arabia Celecoxib API Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 71. South Africa Celecoxib API Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. Celecoxib API Market Drivers
    Figure 73. Celecoxib API Market Restraints
    Figure 74. Celecoxib API Market Trends
    Figure 75. Porters Five Forces Analysis
    Figure 76. Manufacturing Cost Structure Analysis of Celecoxib API in 2022
    Figure 77. Manufacturing Process Analysis of Celecoxib API
    Figure 78. Celecoxib API Industrial Chain
    Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 80. Direct Channel Pros & Cons
    Figure 81. Indirect Channel Pros & Cons
    Figure 82. Methodology
    Figure 83. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Celecoxib API Supply, Demand and Key Producers, 2023-2029

Global Celecoxib API Supply, Demand and Key Producers, 2023-2029

date 22 Mar 2023

date Pharma & Healthcare

The global Celecoxib API market size is expected to reach $ 79 million by 2029, rising at a market growth of 4.7% CAGR during the forecast period (2023-2029).

Global Celecoxib API Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Celecoxib API Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Celecoxib API market size was valued at USD 58 million in 2023 and is forecast to a readjusted size of USD 79 million by 2030 with a CAGR of 4.7% during review period.

Global Celecoxib API Supply, Demand and Key Producers, 2024-2030

Global Celecoxib API Supply, Demand and Key Producers, 2024-2030

date 02 Apr 2024

date Pharma & Healthcare

The global Celecoxib API market size is expected to reach $ 79 million by 2030, rising at a market growth of 4.7% CAGR during the forecast period (2024-2030).

Product Tags

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>